期刊文献+

非衍生化串联质谱技术分析0~2岁儿童死亡与先天性遗传代谢性疾病的关系 被引量:5

Relationship between deaths and congenital genetic metabolic diseases in 0~2 years old children by using of non-derivative tandem mass spectrometry
原文传递
导出
摘要 目的探讨先天性遗传代谢性疾病与0~2岁儿童死亡的关系和串联质谱技术筛查先天性遗传代谢性疾病的可行性。方法对170例北京市2011年和2012年死亡的0~2岁儿童用串联质谱技术检测其新生儿期采集的滤纸干血片中11种氨基酸代谢指标和13种脂肪酸指标水平,将170例分为0~3、4~6、7~12、13~24月四组,分析每组的儿童死亡人数、出生体重、母亲孕周与氨基酸代谢水平和脂肪酸代谢水平及有机酸代谢障碍之间的关系。结果 170例死亡儿童中有氨基酸代谢指标异常5例,脂肪酸代谢指标异常7例,有机酸代谢障碍4例,共16例,占分析死亡人数的9.4%。0~3月组死亡108例,异常9例,占异常总数的56.25%(9/16);4~6月组死亡26例,异常4例,占异常总数的25.0%(4/16);7~12月组死亡26例,异常3例,占异常总数的18.75%(3/16);13~24月组死亡10例,异常0例。结论先天性遗传代谢性疾病是造成儿童死亡的原因之一,快速、灵敏、特异的串联质谱技术是早期评价先天性遗传代谢性产物异常的有效方法。 Objective To explore the relationships between congenital genetic metabolic disease with unknown cause death of 0- 2 years old children and tandem mass spectrometry technology feasibility of screening for congenital genetic metabolic diseases. Methods The level of 11 kinds of amino acid metabolism and 13 kinds of fatty acid indicators were de- tected in 170 cases of 042 years old deaths children with tandem mass spectrometry,170 patients specimens of Beijing area from 2011 to 2012 were divided into 043,4-6,7-12,13-24 months groups,and analysed the relationship between birth weight,gestational, amino acid metabolism, fatty acid metabolism and the organic acid metabolism disorder in each group. Results In a total of 170 cases,children with amino acid metabolism abnormalities were 5 cases,fatty acid metabolism ab- normalities were 16 cases,accounting for 9.4% of deaths. 108 cases died in 0-3 months group with 9 cases of abnormal,ac- counting for 56.25% of total abnormalities (9/16);26 cases died in 4-6 group with abnormal in 4 cases,accounting for 25.0% of the total number of anomalies (4/16);26 cases died in 7 -9 group with 3 cases of abnormal, accounting for 18.75% of the total number of anomalies (3/16);10 patients died in 13424 months group and found no abnormalities. Conclusion Congenital genetic metabolic diseases is the causes of children death, rapid, sensitive and specific technology of tandem mass spectrometry is an effective method to early assess products of congenital abnormal genetic metabolic.
出处 《中国儿童保健杂志》 CAS 北大核心 2013年第10期1024-1028,共5页 Chinese Journal of Child Health Care
关键词 先天性遗传代谢性疾病 死亡 氨基酸 脂肪酸 串联质谱 congenital genetic metabolic diseases death amino acids fatty acids tandem mass spectrometry
  • 相关文献

参考文献13

  • 1顾学范,韩连书,高晓岚,杨艳玲,叶军,邱文娟.串联质谱技术在遗传性代谢病高危儿童筛查中的初步应用[J].中华儿科杂志,2004,42(6):401-404. 被引量:142
  • 2黄新文,杨建滨,童凡,杨茹莱,毛华庆,周雪莲,黄晓磊,杨莉丽,黄成刚,赵正言.串联质谱技术对新生儿遗传代谢病的筛查及随访研究[J].中华儿科杂志,2011,49(10):765-770. 被引量:89
  • 3Chace DH,Kalas TA,Naylor EW. Use of tandem mass spec-trometry for mullianalyLe screening of dried blood speci-mensfrom newborns^J], Clin Chem,2003,49:1797-1817.
  • 4Chace DH, DiPerna JC, Mitchell BL, el al. Electrospray tan-dem mass spectrometry for analysis of acylcarnitines in driedpostmortem blood specimens collected at autopsy from in-fants with unexplained cause of death[J]. Clin Chem,2001,47:1166-1182.
  • 5Strnadova KA,Holub M,hi AM,et al. Long-term stability ofamino acids and acylcarnitines in dried blood spots[J]. ClinC7^m,2007,53:717-722.
  • 6Oglesbee D, Sanders KA,Laceyal. Second-tier test forquantification of alloisoleucine and branched-chain aminoacids in dried blood spots to improve newborn screening formaple syrup urine disease (MSUD)[J]. Clin Chem ,2008,54 :542-549.
  • 7Turgeon CT, Magera MJ , Cuthbert CD, et al. Determinationof total homocy.steine,methylmalonic acid, and 2-methylcirricacid in dried blood spots by tandem mass spectrometry[J].Clin Chem,2010,56:1686-1695.
  • 8Tortorelli S,Turgeon CT,Limal. A two-tier approachto the newborn screening of methylenetetrahydrofolatc re-ductase deficiency and other remethylation disorders by tan-dem mass spcctroniet ry[ J J. J Pecliatr , 2010.157 : 271-275.
  • 9Wanders RJA,Ruiter JPN, IJlst L,et al. The enzymology ofmitochondrial fatty acid beta-oxidation and its application tofollow-up analysis of positive neonatal screening resuhs[J], JInherit Metab Dh,2010,33:479-494.
  • 10Dietzen DJ , Rinaldo P, Whitley RJNational academyof clinical biochemistry laboratory medicine practice guide-lines: follow-up testing for metabolic disease idenlified byexpanded newborn screenin using tandem mass spectromc-try ; executive summary [ J ]. Clin Chem, 2009, 55:1615-1626.

二级参考文献40

  • 1顾学范,韩连书,高晓岚,杨艳玲,叶军,邱文娟.串联质谱技术在遗传性代谢病高危儿童筛查中的初步应用[J].中华儿科杂志,2004,42(6):401-404. 被引量:142
  • 2Millington DS, Kodo N, Norwood DL, et al. Tandem mass spectrometry: a new method for acylcamitine profiling with potential for neonatal screening for inborn errors of metabolism. J Inherit Metab Dis, 1990,13:321-324.
  • 3Scriver CR, Beaudet AL, Sly WS, et al. The Metabolic and Molecular Bases of Inherited Disease. 8th ed, New-York: McGraw-Hill, 2001 : 1667-2239.
  • 4中华人民共和国卫生部.新生儿疾病筛查技术规范(2010年版).http://www.moh.gov.cn/publicfiles/business/htmlfiles/mohfybjysqwss/s3585/201012/50065.htm,[2010-12-01].
  • 5Wilcken B, Wiley V, Sim KG, et al. Camitine transporter defect diagnosed by newborn screening with electrospray tandem mass spectrometry. J Pediatr, 2001,138:581-584.
  • 6Niu DM, Chien YH, Chiang CC, et at. Nationwide survey of extended newborn screening by tandem mass spectrometry in Taiwan. J Inherit Metab Dis, 2010, 33 Supp! 2:295-305.
  • 7Schulze A, Lindner M, Kohlmuller D, et al. Expanded newborn screening for inborn errors of metabolism by electrospray ionization- tandem mass spectrometry: results, outcome, and implications. Pediatrics ,2003,111 : 1399-1406.
  • 8Schulze A, Mayatepek E, Hoffmann GF. Evaluation of 6-year application of the enzymatic colorimetric phenylalanine assay in the setting of neonatal screening for phenylketonuria. Clin Chim Acta, 2002,317 : 27-37.
  • 9Chace DH, DiPema JC, Mitchell BL, et al. Electrospray tandem mass spectrometry for analysis of acylcarnitines in dried postmortem blood specimens collected at autopsy from infants with unexplained cause of death. Clin Chem, 2001,47 : 1166-1182.
  • 10Turgeon C, Magera MJ, Allard P, et al. Combined newborn screening for succinylacetone, amino acids, and acylcarnitines in dried blood spots. Clin Chem, 2008,54:657-664.

共引文献266

同被引文献44

  • 1顾学范,韩连书,高晓岚,杨艳玲,叶军,邱文娟.串联质谱技术在遗传性代谢病高危儿童筛查中的初步应用[J].中华儿科杂志,2004,42(6):401-404. 被引量:142
  • 2韩连书.27万新生儿串联质谱遗传代谢病筛查及随防结果分析[C].中华医学会第十五次全国儿科学术大会论文汇编(上册),2010.
  • 3Varan A, Yazici N, Akalan N, et al.Primitive neuroectodermal tumors of the central nervous system associated with genetic and metabolic defects[J]. J NeurosurgSci, 2012, 56(1): 49-53.
  • 4Schulze A, Kohlmueller D, Mayatepek E. Sensitivity of a electrosparay-tandem mass spectrometry using thephenylalanine/ tyrosine-ratio for differential diagnosis of hyperpheny lalaninemia in neonates[J].Clin Chem Acta, 1999, 283:15-20.
  • 5Gulack BC,Schweitzer M,Englum BR,et al.Predictors of gastrostomy placement in children with inherited metabolic diseases treated by umbilical cord blood transplantation[J].J Pediatr Surg,2015,50(7):1109-1111.
  • 6Millington DS,Kodo N,Norwood DL,et al.Tandem mass spectrometry:a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism[J].J Inherit Metab Dis,1990,13(3):321-324.
  • 7Vogiatzis CG,Zachariadis GA.Tandem mass spectrometry in metallomics and the involving role of ICP-MS detection:a review[J].Anal Chim Acta,2014,819:114.
  • 8Hui J,Tang NL,Li CK,et al.Inherited metabolic diseases in the southern Chinese population:spectrum of diseases and estimated incidence from recurrent mutations[J].Pathology,2014,46(5):375-382.
  • 9江剑辉,曹伟锋,姜迪刚,李蓓,蒋翔,贾雪芳,林本蘅,陈倩瑜,顾学范,韩连书.748例遗传性代谢病高危儿童串联质谱筛查研究[J].广东医学,2008,29(3):357-359. 被引量:31
  • 10刘伟.串联质谱—新生儿疾病筛查技术的发展趋势[J].中国妇幼卫生杂志,2011,2(1):42-44. 被引量:18

引证文献5

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部